Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Collegium Pharmaceutical Inc. (COLL)

23.13   -0.88 (-3.67%) 02-14 16:00
Open: 24.31 Pre. Close: 24.01
High: 24.795 Low: 23.09
Volume: 1,071,570 Market Cap: 775M
Collegium Pharmaceutical Inc is a specialty pharmaceutical company which is engaged in developing and planning to commercialize abuse-deterrent products through its patented DETERx platform technology.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 24.811 - 24.977 24.977 - 25.116
Low: 22.785 - 22.94 22.94 - 23.069
Close: 22.904 - 23.154 23.154 - 23.362

Technical analysis

as of: 2020-02-14 4:27:36 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 29.89     One year: 34.91
Support: Support1: 21.72    Support2: 19.33
Resistance: Resistance1: 25.59    Resistance2: 29.89
Pivot: 21.73
Moving Average: MA(5): 23.03     MA(20): 21.74
MA(100): 18.04     MA(250): 15.15
MACD: MACD(12,26): 0.56     Signal(9): 0.32
Stochastic oscillator: %K(14,3): 70.87     %D(3): 63.37
RSI: RSI(14): 54.56
52-week: High: 25.59  Low: 10.01  Change(%): 53.8
Average Vol(K): 3-Month: 57040  10-Days: 161315

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
COLL has closed below upper band by 28.7%. Bollinger Bands are 53.1% wider than normal. The large width of the bands suggest high volatility as compared to COLL's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Stock To Watch: Collegium Pharmaceutical (COLL)
Collegium Pharmaceutical Inc. (COLL) is currently trading at $23.28, an increase of 4.82 percent from the previous closing price of $22.82..

The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 16.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Arvinas Inc (NASDAQ: ARVN ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) ChemoCentryx Inc (NASDAQ: CCXI ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) DENTSPLY SIRONA Inc (NASDAQ: XRAY ) Eli Lilly And Co (NYSE: LLY ) Epizyme Inc (NASDAQ: EPZM ) Fate Therapeutics Inc (NASDAQ: FATE ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Fortress Biotech (NASDAQ: FBIO ) (announced award of pediatric disease designation for its partner company Cyprium's CUTX-101, which is being evaluated for Menkes disease) Frequency Therapeutics Inc (NASDAQ: FREQ ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Hologic, Inc. (NASDAQ: HOLX ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) Inspire Medical Systems Inc (NYSE: INSP ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ Medtronic PLC (NYSE: MDT ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Mesoblast limited (NASDAQ: MESO ) Minerva Neurosciences Inc (NASDAQ: NERV ) Nantkwest Inc (NASDAQ: NK ) …

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 33.53
Shares Float (M) 32.92
% Held by Insiders 1.69
% Held by Institutions 100.05
Shares Short (K) 1660
Shares Short P. Month (K)

Stock Financials

EPS -0.340
Book Value (p.s.) 2.510
PEG Ratio -49.78
Profit Margin -3.86
Operating Margin -3.51
Return on Assets (ttm) -1.4
Return on Equity (ttm) -14.8
Qtrly Rev. Growth 3.9
Gross Profit (p.s.) 3.422
Sales Per Share
EBITDA (p.s.) 0.509
Qtrly Earnings Growth
Operating Cash Flow (M) 54.41
Levered Free Cash Flow (M) -70.45

Stock Valuations

P/E -68.03
P/E Growth Ratio -0.04
P/BV 9.22
P/S 2.59
P/CF 14.25

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.